#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypochromic anaemia Deafness Cardiac amyloidosis IgA nephropathy Thrombotic thrombocytopenic purpura Myelodysplastic syndrome Haemophilia A with anti factor VIII Undifferentiated sarcoma Huntington's disease Amyloidosis Acute graft versus host disease in skin Stiff person syndrome Breast angiosarcoma Systemic scleroderma Acute lymphocytic leukaemia More trials…

    Learn about Rare Diseases

    VEXAS syndrome – Basic Information Synovial sarcoma – Diagnostics Breast angiosarcoma – Life with Disease Congenital hypotransferrinaemia Glomerulonephritis membranous – Treatment Systemic sclerosis pulmonary Hyperoxaluria – Diagnostics Breast angiosarcoma – Trials in Disease Nodal marginal zone B-cell lymphoma – Life with Disease Breast angiosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ck-0045 VANADIUM OXIDE SULFATE GSKVX000000030825 Zinc Acetate Dihydrate Tucidinostat Cinnarizine Quetiapine Glipizide SPY002 Adezunap Rifabutin Tenofovir Disoproxil Elexacaftor CAL101 Tedizolid Phosphate L-PHENYLALANINE Pasireotide Diaspartate Felzartamab Dinutuximab Beta Ttf-Ngr More therapies…

    Learn about Your Condition

    Ovarian granulosa cell tumour Pelizaeus-Merzbacher disease Brain cancer metastatic Malabsorption Neurodevelopmental disorder Vasospasm Tuberous sclerosis complex Hernia repair Hepatic adenoma Phenylketonuria Anal incontinence Dengue fever Follicular thyroid cancer Congenital pseudarthrosis Diminished ovarian reserve More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Ziekenhuis Gelderse Vallei Stichting

Ziekenhuis Gelderse Vallei Stichting

Willy Brandtlaan 10, Ede, 6716 RP, Netherlands

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Zalunfiban for Patients with ST-Elevation Myocardial Infarction (Heart Attack)

    Not recruiting

    3 1
    Investigated Diseases:
    • Acute cardiac event
    • Acute myocardial infarction
    • Myocardial ischaemia
    Investigated Drugs:
    • Zalunfiban
    Czechia France Hungary The Netherlands Romania

  • Study on Atezolizumab for Patients with High-Risk Diffuse Large B-Cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Atezolizumab
    Belgium The Netherlands

  • Study on Aspirin for Preventing Recurrence and Improving Survival in Patients with Stage II and III Colon Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer stage II
    • Colon cancer stage III
    Investigated Drugs:
    • Placebo
    • Acetylsalicylic Acid
    The Netherlands

  • Study of ISIS 678354 for Patients with Severe Hypertriglyceridemia

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Isis 678354 Sodium Salt
    Belgium Bulgaria Czechia Denmark Finland France +13

  • Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    • Milvexian
    Austria Belgium Bulgaria Croatia Czechia Denmark +14

  • Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Andexanet Alfa
    • Apixaban
    • Milvexian
    Belgium Bulgaria Croatia Czechia Denmark Estonia +13

  • Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Inclisiran
    Austria Belgium Bulgaria Croatia Czechia Denmark +14

  • Study of RO7247669 and Nab-Paclitaxel vs. Pembrolizumab and Nab-Paclitaxel for Patients with Untreated, PD-L1 Positive, Advanced Triple-Negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Czechia Denmark Germany Hungary Italy The Netherlands +2

  • Study on Midostaurin and Decitabine for Adults with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Who Are Unfit for Intensive Treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Midostaurin
    • Decitabine
    Belgium The Netherlands

  • Study on Liposomal Irinotecan, Carboplatin, or Oxaliplatin for First-Line Treatment in Patients with Advanced Esophagogastric Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastrooesophageal cancer
    Investigated Drugs:
    • Capecitabine
    • Carboplatin
    • Fluorouracil
    The Netherlands
Previous Page
1 … 3 4 5 6
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!